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A B S T R A C T
Objective: Subﬁeld-speciﬁc measurements provide superior information in the early stages of neurodegenerative
diseases compared to global hippocampal measurements. The overall goal was to systematically compare the
performance of ﬁve representative manual and automated T1 and T2 based subﬁeld labeling techniques in a sub-
set of the ADNI2 population.
Methods: The high resolution T2 weighted hippocampal images (T2-HighRes) and the corresponding T1 images
from 106 ADNI2 subjects (41 controls, 57 MCI, 8 AD) were processed as follows. A. T1-based: 1. Freesurfer
+ Large-Diﬀeomorphic-Metric-Mapping in combination with shape analysis. 2. FreeSurfer 5.1 subﬁelds using in-
vivo atlas. B. T2-HighRes: 1. Model-based subﬁeld segmentation using ex-vivo atlas (FreeSurfer 6.0). 2. T2-based
automated multi-atlas segmentation combined with similarity-weighted voting (ASHS). 3. Manual subﬁeld
parcellation. Multiple regression analyses were used to calculate eﬀect sizes (ES) for group, amyloid positivity in
controls, and associations with cognitive/memory performance for each approach.
Results: Subﬁeld volumetry was better than whole hippocampal volumetry for the detection of the mild atrophy
diﬀerences between controls and MCI (ES: 0.27 vs 0.11). T2-HighRes approaches outperformed T1 approaches
for the detection of early stage atrophy (ES: 0.27 vs.0.10), amyloid positivity (ES: 0.11 vs 0.04), and cognitive
associations (ES: 0.22 vs 0.19).
Conclusions: T2-HighRes subﬁeld approaches outperformed whole hippocampus and T1 subﬁeld approaches.
None of the diﬀerent T2-HghRes methods tested had a clear advantage over the other methods. Each has
strengths and weaknesses that need to be taken into account when deciding which one to use to get the best
results from subﬁeld volumetry.
1. Introduction
Hippocampal neuronal and/or glial dysfunction or neuronal loss
severe enough to cause hippocampal volume loss in quantitative mag-
netic resonance imaging (MRI) is a common feature of many brain
disorders, e.g., Alzheimer's disease, multiple sclerosis, epilepsy, schi-
zophrenia, post-traumatic stress syndrome, Parkinson's disease or
traumatic brain injury (Miller and O'Callaghan, 2005; West et al., 1994;
Papadopoulos et al., 2009; Bluemcke et al., 1999; Harrison, 2004;
McEwen and Magarinos, 1997, Swartz et al., 2006, Pereira et al., 2013).
Even non-brain disorders, e.g., hypertension, hypothyroidism or dia-
betes (Cooke et al., 2014; Petrovitch et al., 2000; Korf et al., 2006) can
be associated with hippocampal abnormalities. The hippocampus is not
a homogeneous structure but consists of several histologically and
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functionally specialized but nonetheless tightly interconnected sub-
ﬁelds: the subiculum (SUB) which is subdivided into the prosubiculum,
subiculum proper, pre- and parasubiculum, the cornu ammonis sectors
(CA) 1–3 and the dentate gyrus (DG) (Duvernoy et al., 2013). Animal
and histopathological studies have shown that diﬀerent pathological
conditions aﬀect subﬁelds diﬀerently, e.g., Alzheimer's disease and
hypoxia damage CA1, schizophrenia CA2, traumatic brain injury and
post-traumatic stress syndrome CA3 and temporal lobe epilepsy da-
mages the dentate gyrus (e.g., West et al., 1994; Fukutani et al., 2000;
Bluemcke et al., 1999; Lucassen et al., 2006; Baldwin et al., 1997;
Bluemcke et al., 2007). These observations suggest that subﬁeld speciﬁc
information might allow for a better diﬀerentiation of diﬀerent disease
processes and consequently for an earlier diagnosis than total hippo-
campal volume (Small, 2014).
The advent of high ﬁeld (3 Tesla and higher) MRI platforms and the
possibility to acquire high resolution images of the hippocampal for-
mation depicting details of its internal structure within a few minutes
resulted in the development of a growing number of manual and
computational subﬁeld labeling approaches. These techniques were
applied to a variety of diseases in small single-site studies and usually
found subﬁeld volumetry to be superior to standard whole hippocampal
volumetry for the detection of hippocampal damage in the early stages
of the disease process, for diﬀerentiating between diseases or for the
investigation of structure/function relationships (e.g., Wang et al.,
2006; Ballmaier et al., 2008; Mueller et al., 2008; Schobel et al., 2009;
Neylan et al., 2010; Bender et al., 2013; Kerchner et al., 2014; Schoene-
Bake et al., 2014; Chao et al., 2014; Hsu et al., 2015; De Flores et al.,
2015; Pluta et al., 2012; Yushkevich et al., 2015b). The promise of
hippocampal subﬁeld volumetry techniques however led to two un-
expected developments that could potentially limit the usefulness of
this approach. One is the lack of standardized boundary deﬁnitions for
each subﬁeld that complicates the comparison of results from diﬀerent
laboratories. This problem has been recognized by the research com-
munity and is now being addressed by an international work group that
will develop a harmonized subﬁeld labeling protocol (Yushkevich et al.,
2015a; Wisse et al., 2017) using a similar approach as for the harmo-
nization of the outer hippocampus boundaries (Boccardi et al., 2011).
The other development is the variety of available labeling techniques
(e.g., Pipitone et al., 2014; Kim et al., 2014; Zeineh et al., 2001;
Thompson et al., 2004; Chatelat et al., 2008; Goubran et al., 2014).
Each of them has its strengths and weaknesses which can complicate
the comparison of ﬁndings across laboratories but also confuse re-
searchers new to this ﬁeld who must decide which of the available
technique ﬁts their needs best.
The goal of this study was not to compare all existing subﬁeld la-
beling approaches/protocols but to concentrate on the performance of
ﬁve commonly used approaches (4 automated, 1 manual labeling) in a
common data set. These techniques were selected because each re-
presents a diﬀerent approach for subﬁeld labeling and because all au-
tomated approaches except one are publicly available and used by the
research community. The intention was not to determine which of these
four approaches captures the disease speciﬁc pathology best because
this is not possible without a ground truth, i.e. histopathological con-
ﬁrmation, but rather to compare where they ﬁnd the most prominent
diﬀerences between groups and how large the diﬀerences are. The ideal
common data set for such a comparison consists of a large population of
well-characterized subjects who show the whole range of normal age-
related to severely disease related hippocampal atrophy. This data set
became available when the steering committee of the Alzheimer's
Disease Neuroimaging Initiative (ADNI) added a high resolution hip-
pocampal sequence to the ADNI MR protocol in a subset of the ADNI
sites (cf. Methods).
Based on the image type used for the parcellation two main subﬁeld
volumetry approaches can be distinguished. 1. Approaches using a
whole brain T1 weighted image typically at a resolution of 1 mm iso-
tropic or close to that resolution, e.g., shape analysis, radial distance
technique, voxel-based morphometry or deformation-based morpho-
metry (Csernansky et al., 1998; Chatelat et al., 2008; Thompson et al.,
2004; Yushkevich et al., 2010a). Of the currently available T1-based
approaches, the Bayesian inference labeling as implemented in Free-
surfer 5.1. (Van Leemput et al., 2009) and shape analysis based on
Large Deformation Diﬀeomorphic Metric Mapping (Khan et al., 2008)
were selected for this project. The former because the algorithm is
publicly available and is frequently used, and the second because it was
one of the earliest approaches for subﬁeld volumetry that has been
continuously reﬁned and optimized for 3 T images. 2. Approaches using
a T2 weighted hippocampal image. These images are characterized by a
submillimeter in plane resolution but thick slices to increase S/N and
therefore depict more details of the internal structure than a T1 image.
This has been exploited by manual labeling approaches and increas-
ingly also by automated approaches. Of the currently available ap-
proaches ASHS (Yushkevich et al., 2015b) and the latest version of
Bayesian inference labeling implemented in Freesurfer 6.0 (Iglesias
et al., 2015) were chosen for this project because both algorithms are
publicly available and are used by the larger research community. The
manual labeling protocol developed by Mueller et al. (2007) was
chosen as manual reference because its limited labeling scheme made it
possible to label the over 100 images required for this project within a
reasonable amount of time. The selected approaches use diﬀerent la-
beling protocols which prevents a direct comparison of the subﬁeld
volumes. Instead of focusing on the subset of subﬁelds known to show
atrophy and other histopathological features of AD from autopsy stu-
dies, e.g., subiculum, CA1, it was therefore decided in a ﬁrst step to
calculate the eﬀect sizes for each and every subﬁeld provided by the
approach and compare the performance of the subﬁelds with the largest
eﬀect size for each approach regardless of biological plausibility. This
provides the type of information that is needed to determine which one
of the approaches evaluated here is the most cost eﬃcient in a clinical
trial that uses subﬁeld volumetry as an outcome measure. In a second
step, it was investigated how well the ﬁndings reﬂected the pattern of
subﬁeld atrophy described in histopathological studies of AD. The in-
tention was to compare the performance of these approaches over the
whole range of Alzheimer's disease (AD) related hippocampal atrophy
and thus the following comparisons were chosen:
1. Ability to detect a group eﬀect for subﬁeld and mesio-temporal
volumes in a population consisting of cognitively normal older
controls, non-demented subjects with diﬀerent degrees of mild
cognitive impairment and subjects diagnosed with AD (group).
2. Ability to detect subﬁeld and mesio-temporal volumes losses in non-
demented subjects with diﬀerent degrees of mild cognitive impair-
ment (MCI) compared to cognitively normal elderly controls (MCI).
3. Ability to detect an eﬀect of amyloid positivity on subﬁeld and
mesio-temporal volumes in cognitively normal subjects (Abeta)
which is the stage when treatment with a disease modifying drug
would be most eﬃcient.
4. Ability to detect a signiﬁcant association between general cognitive
performance/memory performance and subﬁeld and mesio-tem-
poral volumes in cognitively normal subjects (ADAScog and RVLT).
2. Methods
Data used in the preparation of this article were obtained from the
Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.
loni.usc.edu). The ADNI was launched in 2003 as a public-private
partnership, led by Principal Investigator Michael W. Weiner, MD. The
primary goal of ADNI has been to investigate which combination of the
measures obtained by serial magnetic resonance imaging (MRI),
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positron emission tomography (PET), other biological markers, and
clinical and neuropsychological assessments allows for the most eﬃ-
cient monitoring of the progression of mild cognitive impairment (MCI)
and early Alzheimer's disease (AD). The initial ADNI was followed by
ADNI GO, ADNI 2 and now ADNI 3. To date these 3 projects have re-
cruited> 1500 55–90-year-old participants who were either cogni-
tively normal or diagnosed with early (EMCI), late (LMCI) mild cog-
nitive impairment or with early AD. The ADNI2 hippocampal subﬁeld
project was not part of the original ADNI2 project and was made pos-
sible by a grant of the Alzheimer's Association. It consisted of three
phases. Phase 1: 2011–2012 harmonization and modiﬁcation (reduc-
tion of acquisition time to 8 min) of existing high resolution T2 hip-
pocampus 3 T sequences. Phase 2: January 2012–December 2012:
Testing the performance of existing subﬁeld algorithms on ADNI2
imaging data and modiﬁcation to optimize performance, e.g., devel-
opment of strategies to allow for partial coverage, testing of diﬀerent
atlases, quality control routines etc. Phase 3. Evaluation phase: January
2013–December 2015. Identiﬁcation of ﬁnal study population and data
processing
2.1. MRI acquisition
The ADNI2 MRI protocol has been optimized to provide comparable
images from diﬀerent 3 T platforms from the three major vendors
Siemens, Philips and General Electric. The high resolution hippocampus
sequence was added to the existing ADNI2 imaging protocol of 20 sites
with Siemens magnets in December 2012 and acquired at the end of the
oﬃcial protocol. The following images were used for this project: 1. T1
weighted MPrage TR/TE/TI 2300/2.95/900 ms, sagittal,
1.1 × 1.1 × 1.2 mm resolution. 2. T2 weighted turbo spin echo TR/TE
8020/50 ms, inplane resolution 0.4 × 0.4 mm, slice thickness 2 mm, 28
or 32 slices, coronal, oriented perpendicularly to the long axis of the
hippocampus covering the hippocampal head and body but not always
the tail in all cases (please see adni.loni.usc.edu/methods/documents/
mri-protocols/ Siemens sequences for details).
2.2. Image quality control
684 high resolution exams of 393 diﬀerent subjects had been ac-
quired between December 2012 and November 2015. The image
quality was systematically assessed by trained raters for: hippocampus
coverage (full/head and body or incomplete), correctness of FOV an-
gulation regarding the hippocampal axes (meeting speciﬁcation or not
meeting speciﬁcation), contrast/noise of internal structure of hippo-
campus (good, moderate, bad), severity of motion artifacts (good,
moderate, severe) and other (e.g., artifacts from vessels, pathology).
543 high resolution images from 349 diﬀerent subjects passed quality
control. 84 exams were rejected due to severe motion artifacts which
were typically associated with bad contrast/noise. 57 exams were ex-
cluded due to positioning errors resulting in incomplete coverage of
hippocampal head and body or incorrect angulation. Please see
Supplementary material for list of images selected for this project.
2.3. Study population
The images from 106 diﬀerent subjects were selected for further
processing. The reason to focus only on a subset of all available exams
was the limited processing capacity of the manual subﬁeld labeling arm
that had only one qualiﬁed rater. Subjects were selected based on the
availability of clinical diagnosis, results of the ﬂorbetapir amyloid PET
(cut oﬀ for amyloid positivity: 1.11) and neuropsychological exam at
the timepoint of the selection. Since the intent was to compare the
techniques regarding their performance in the early stages of the dis-
ease, MCI and healthy controls were preferentially selected. Please see
Table 1 for demographic information etc. The cognitive functioning of
all subjects had been assessed with the standardized ADNI test battery.
The Alzheimer's Disease Assessment Scale – cognition (ADAScog) and
the immediate recall of the Rey Auditory verbal learning test were
chosen from that battery. The former is a measure of global cognitive
performance and was expected to show associations with subﬁelds
diﬀerentiating between cognitively intact and mildly impaired subjects.
The latter was chosen as a hippocampus speciﬁc measure for encoding/
learning and was expected to show an association with CA3 and/or
dentate gyrus volume (Mueller et al., 2011). (See Fig. 1.)
2.4. Image processing
2.4.1. High resolution T2 sequences
2.4.1.1. Manual labeling. Input: Resampled high resolution T2
hippocampal image to obtain images where the hippocampal cross-
section is perpendicular to the long axis of the left and the right
hippocampus.
Output: Left and right label masks in space of resampled image and
text ﬁle with volumes covered by labels.
Parcellation scheme and atlas: Rview (www.colin-studholme.net/
software/software.html) is used for display and labeling. Labels for
entorhinal cortex, subiculum, CA1, CA2 and dentate gyrus & CA3 are
generated.
Validation: NA.
Customization: Label deﬁnition and region to be labeled can be
customized.
Quality control: Consistency check, i.e., each label is checked after
ﬁrst pass labeling for labeling accuracy and consistency after processing
the complete study population and manually edited if necessary before
transferring the volumes into the project database.
Computing power: Standard desktop computer with 2.80GHz CPU
and 6.00 GB RAM. The resampling step (preparation and computation
of left and right hippocampus) takes ca. 1.5 h/subject, manual labeling
ca. 60–90 min/subject for an experienced rater.
Brief method summary: The labeling method including assessment
of measurement reliability has been described in detail previously
(Mueller et al., 2007, 2010). In brief, the marking scheme depends on
anatomical landmarks, particularly on a hypointense line representing
myelinated ﬁbers in the stratum moleculare/lacunosum which can be
reliably visualized on these high resolution images. Together with ex-
ternal landmarks, e.g., ﬁmbria, collateral sulcus etc. this line is used to
identify and manually label the subiculum, the cornu ammonis sectors
CA1-CA3 and the dentate gyrus on a length of about 1 cm in the
Table 1
Study population demographics.
Group Normal MCI AD
No 41 57 8
Female/male 22/19 22/35 4/4
Age 75.1 (7.6) 71.1 (7.6) 75.6 (9.0)
Apo E4 pos 10 22 4
SUVR 1.12 (0.21) 1.21 (0.23) 1.41 (0.13)
CDR SB 0.11 (0.38) 1.80 (1.54) 4.56 (1.43)
MMSE 28.8 (1.5) 27.4 (2.8) 21.0 (3.8)
ADAScog 8.4 (4.6) 15.2 (10.0) 31.8 (9.0)
RVLT immediate 47.1 (10.8) 39.7 (13.8) 20.6 (6.1)
RVLT learning 5.8 (2.4) 4.6 (3.1) 2.1 (1.5)
RVLT forgetting 3.8 (3.3) 4.6 (3.1) 4.0 (1.3)
Apo E4 pos, at least one Apo E4 allele; SUVR standardized uptake.
Value ratio relative to cerebellar gray CDR SB, clinical dementia rating scale sum of
boxes.
ADAS cog, Alzheimer's Disease Assessment Scale – cognition.
MMSE, Mini-Mental-State-Exam; RVLT, Rey verbal learning test.
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anterior third of hippocampal body. For the sake of eﬃciency, the la-
beling section is restricted to the anterior section of the hippocampal
body (ca. 60–90 min/subject for an experienced rater).
Limitations: Specially trained rater required, time consuming.
Method requires the acquisition of suitable high resolution T2 images.
2.4.1.2. Automated segmentation of hippocampal subﬁelds (ASHS). Input:
T1-MRI and high resolution T2 hippocampal image.
Output: Left and right multi-label images and text ﬁle with volumes
of each subregion.
Parcellation scheme and atlas: Labels for hippocampal subﬁelds
CA1–3 and CA4/DG, subiculum, and extrahippocampal cortical regions
parahippocampal cortex, entorhinal cortex, BA35 and BA36 together
constituting perirhinal cortex, are generated. The atlas provided with
the public distribution of the software consists of 28 subjects in whom
the subﬁelds were labeled manually by an experienced rater. The atlas
population consists of an almost equal proportion of older healthy
control and amnestic mild cognitive impairment (aMCI) patients. The
method has recently been adapted to 7 T, the latest software release
includes a 7 T atlas (Wisse et al., 2016).
Validation: This method has been validated using k-fold cross-vali-
dation against manual segmentation in an in-vivo dataset of older
healthy controls and aMCI patients (Yushkevich et al., 2015b).
Customization: The method can be adapted regarding number and
deﬁnition of labels and also regarding atlas images, i.e., it is possible to
generate a customized library. Training software is provided as part of
the package to utilize such a customized library. A set of 20 atlas images
is suﬃcient.
Quality control: Label images can be displayed overlaid on T2
hippocampal images with ITK snap software (www.itksnap.org) and
edited if necessary. Manual editing was not performed on the data
presented in this paper.
Computing power: The method is based on a multi-atlas technique
that requires multiple pairwise image registrations, which are ideally
performed in parallel in a computing cluster. The software provides
interface to Sun Grid Engine scheduler to facilitate this. The method
takes 2–3 h to complete on a modern Linux-based cluster.
Brief method summary: This software, named (ASHS) implements a
previously published multi-atlas segmentation technique (Yushkevich
et al., 2010b). Brieﬂy, the target MRI is registered with a bank of T2-
weighted atlas MRIs that includes manually labeled subregions. These
manually derived labels were transferred to the target image to produce
a set of candidate segmentations. A consensus segmentation is obtained
using joint label fusion (Wang et al., 2013a), that takes into account
similarity of each atlas image to the target image. Systematic segmen-
tation errors are corrected using a learning-based biased correction
technique (Wang et al., 2013b) to generate the ﬁnal segmentation. Fi-
nally, a bootstrapping phase repeats joint label fusion and corrective
learning with atlas-to-target registrations seeded by the segmentation
result from the previous phase.
Limitations: The atlas provided with the publicly distributed version
of the software (https://www.nitrc.org/projects/ashs/) is composed of
older healthy controls and mild cognitive impairment patients. This
atlas is suitable for studies in an Alzheimer's disease population or older
healthy subjects, but must be used with caution in a dataset of non-
neurodegenerative pathologies and younger subjects, for which the
results might be non-optimal, particularly if volumetric analysis is de-
sired. The best results should be achieved with a customized population
speciﬁc atlas generated from images generated on the same magnet (cf.
customization).
2.4.1.3. FreeSurfer 6.0 (FS 6.0). Input: T1-MRI and/or high resolution
T2 hippocampal image.
Output: Assuming that both a T1 and a high resolution T2 scan are
provided, the algorithm produces a high resolution T2 image in the
space of input T1 scan and all other FreeSurfer volumes, a left and right
multi-label image with the discrete segmentation of the substructures of
each hippocampus, at 0.333 mm resolution, in the physical space of the
FreeSurfer T1 data and two text ﬁles with the estimated volumes of the
hippocampal substructures and of the whole hippocampus. These vo-
lumes are computed from probabilistic (rather than binary, winner-
take-all) segmentations, so simply counting the number of voxels that
Fig. 1. Parcellation schemes. Manual, manual parcellation labels; green, entorhinal cortex; blue, subiculum; red, CA1; yellow, CA1–2 transition zone; maroon, CA3&dentate. FS 6.0, labels
of Freesurfer 6.0 subﬁeld parcellation; yellow, parasubiculum; purple, presubiculum; blue, subiculum; red, CA1, green, CA2/3; tan, CA4; brown, molecular layer; light blue, GC-DG; light
green, HATA; lilac, ﬁmbria, ASHS parcellation.
FS Sub, Freesurfer 5.1 subﬁeld parcellation labels; yellow, presubiclum; green, subiculum; red, CA1; blue, CA2/3; bright blue, hippocampal ﬁssure; lilac, ﬁmbria; shape analysis, green,
hippocampal boundaries. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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have been labeled as a speciﬁc structure in the discrete segmentation
will not yield the same result as the volume reported in this ﬁle.
Parcellation scheme and atlas: The hippocampal substructures that
are segmented by the software are hippocampal tail; parasubiculum;
presubiculum; subiculum; CA1; CA2 + CA3; CA4; hippocampus–a-
mygdala transition area (HATA); granule cell layer of dentate gyrus
(GC-DG); molecular layer; ﬁmbria; and hippocampal ﬁssure (not in-
cluded for computing the whole hippocampal volume). These structures
were manually labeled in 15 ex vivo scans, and a probabilistic atlas of
hippocampal anatomy was built from these delineations, in combina-
tion with manual segmentations of 39 1 mm T1 scans of the whole brain
at the structure level (i.e., whole hippocampus, whole amygdala, etc.).
These 39 scans are important to learn the deﬁning image features of the
anatomy of the brain structures surrounding the hippocampus (Iglesias
et al., 2015).
Validation: Indirect validation by assessing the ability of the esti-
mated subﬁeld volumes to separate diﬀerent groups (Iglesias et al.,
2015).
Customization: Not possible.
Quality assessment: Labels can be displayed in FreeSurfer's Freeview
to assess label accuracy. Editing is theoretically possible but requires
advanced knowledge of hippocampal anatomy and was not done for
this project.
Computing power: The algorithm takes approximately 30 min to
complete, using a single core.
Brief method summary: The method is based on a probabilistic atlas
of hippocampal anatomy derived from manual segmentations made on
15 ex vivo scans (including four subjects diagnosed with AD) scanned at
(on average) 0.13 mm isotropic resolution. Using a Bayesian algorithm,
these manual delineations were then combined with manual segmen-
tations from 39 1 mm T1 scans (including 10 of subjects diagnosed with
AD) that had been labeled at the whole structure level, to create a single
probabilistic atlas. The atlas is represented as a tetrahedral mesh, in
which each node has a corresponding vector of probabilities for the
diﬀerent structures encoded in the atlas. The mesh is adaptive, such
that more convoluted regions of the atlas are represented by ﬁner tet-
rahedra. Once the atlas has been built, segmentation of the hippo-
campal substructures is posed as a Bayesian inference problem, such
that the probability of the segmentation given the input scan and the
atlas is maximized. The intensities of the voxels in the scan to analyze
are assumed to be samples of a Gaussian mixture model conditioned on
the hidden segmentation. The parameters of this model are learned
directly from the test scan to segment, which makes the method robust
to changes in MRI contrast, and also enables it to immediate generalize
to multispectral MRI data (even when some of the channels do not
completely cover the hippocampal formation), as described in (Iglesias
et al., 2015). Longitudinal labeling has been developed for T1 weighted
images (Iglesias et al., 2016) but not been tested for high resolution T2
images with thick slices.
Limitations: The atlas was built using elderly subjects. Its applic-
ability to studies of younger populations or other diseases has not been
tested. Finally, a drawback of the ability of this method to adapt to the
MRI contrast is that it is not possible to further optimize its performance
by training it in a subset of the imaging data to be segmented.
2.4.2. T1 weighted methods
2.4.2.1. Shape analysis. Input: T1-MRI and hippocampal label
produced by the Freesurfer recon-all stream.
Output: The primary outputs are binary whole-hippocampus seg-
mentations, corresponding hippocampal 2D surfaces and surface-based
subﬁeld delineations. Secondary outputs are multivariate shape indices
and summary shape deformation index (univariate).
Parcellation scheme and atlas: The atlas segmentation is a manually
traced subset of 74 ADNI1 subjects (not part of investigated cohort).
Validation: The three hippocampal surface zones in the right
hemisphere of ten randomly selected subjects were manually outlined
and compared with the surface zones as mapped from the template. The
intra-class correlation coeﬃcients of the areas of the three surface zones
were between 0.90 and 0.97 (Wang et al. 2006).
Customizations: None.
Quality assessment: The method provides a quick-check snapshot
generation step for easy quality assurance.
Computing power: Multi-atlas FS-LDDMM requires multiple pair-
wise image registrations, which are ideally performed in parallel in a
computing cluster. On a modern Linux-based cluster, the method takes
2–4 h to complete. A web portal (http://ceramicca.ensc.sfu.ca/) is
provided for collaborators.
Brief method summary: Hippocampal surfaces were generated from
T1-weighted images of all subjects using multi-atlas FS-LDDMM
(Christensen et al., 2015; Khan et al., 2008; Khan et al., 2013; Wang
et al., 2009). ADNI2 EMCI and control subjects that had not been se-
lected for this analysis were used to deﬁne EMCI-related surface sig-
nature labels. This was done by ﬁrst computing a population average
hippocampal surface and then the vertex-wise deformation for each
subject from this average. Vertex-wise generalized linear model (GLM)
was used to compare the hippocampal deformation between ADNI2
EMCI and controls. Signiﬁcant clusters of vertices were identiﬁed using
Random Field Theory (Taylor and Worsley, 2007; Worsley et al., 1999).
The collection of these vertices in each subﬁeld represent “EMCI sig-
nature labels.” Next, the hippocampal surfaces of the ADNI2 subjects
selected for this project were calculated. The subﬁeld deformation can
be represented in a multivariate or a univariate approach. The former
uses a PCA to determine the principal components (PC) that account for
80% of the shape variance to represent the surface shape. Each subject's
surface is expressed in terms of a linear combination of the PCs with the
weights being a multivariate representation of the shape (Csernansky
et al., 2004). For this analysis, the univariate approach was used, i.e.,
the vertex-wise surface deformation corresponding to each EMCI sig-
nature label was extracted and the mean calculated. This provided a
measure of subﬁeld speciﬁc deformation for each subject that is com-
parable with the other approaches.
2.4.2.2. FreeSurfer subﬁelds version 5.1 (FS sub). Input: T1 image.
Output: label image and text ﬁle with subﬁeld volumes.
Parcellation scheme atlas: Identiﬁes labels for ﬁmbria, CA2–3, CA1,
CA4 and dentate, presubiculum, subiculum, hippocampal ﬁssure, hip-
pocampus (tail) inferior lateral ventricle and choroid plexus based on
information from an probabilistic atlas generated from the manual
segmentations of the right hippocampus in 10 (6 young, 4 older) cog-
nitively intact subjects (Van Leemput et al., 2009).
Validation: Leave-one-out comparison with manual delineations in
ultra-high resolution images.
Customization: Not possible.
Quality control: Each label map was assessed for accuracy, i.e.,
veriﬁed that all subﬁeld labels were within the hippocampus, non-
subﬁeld labels, e.g., ventricle label, were not bleeding in the hippo-
campus and that the hippocampus was completely labeled. No label
editing was done, substandard labels were rejected, only labels from
images that were rated as pass were used in analysis.
Computing power: 5 h per subject on a 2.83 Hz Intel Xeon E5440
processor.
Brief summary: Automated segmentation of hippocampal subﬁelds
using Bayesian inference and a segmentation prior that is deﬁned in the
form of a tetrahedral mesh-based probabilistic atlas in which each mesh
vertex has an associated vector of probabilities for diﬀerent hippo-
campal subﬁelds and surrounding structures of the medial temporal
lobe. The subﬁeld routine implemented in FreeSurfer (version 5.1,
https://surfer.nmr.mgh.harvard.edu) was used for this project.
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Limitations: Simpliﬁed non-anatomical parcellation scheme (Wisse
et al., 2014).
2.4.2.3. FreeSurfer hippocampus version 5.1 (FS Hippo). Input: T1
weighted image.
Output: label mask (aseg_aparc) and text ﬁle.
Parcellation and atlas: Subcortical structures including the hippo-
campi of 39 healthy subjects were manually traced on T1 weighted
images. These scans and their segmentations were then used to build a
joint probabilistic atlas of labels and intensities.
Customization: Not possible.
Quality control: Each aseg_aparc label map including hippocampal
labels was assessed for accuracy. Only hippocampal labels from images
that were rated as full pass (all assessed labels met accuracy criteria)
were used in this analysis.
Computing power: 5 h per subject on a 2.83 Hz Intel Xeon E5440
processor.
Brief summary: The FreeSurfer processing stream consists of the co-
registration of the subject T1 image to an atlas followed by for bias
correction, intensity normalization and brain extraction/removal of
non-brain tissue. The subcortical structures are labeled by co-re-
gistering the subject brain to a probabilistic labeled template in
Talairach space. FreeSurfer version 5.1, (https://surfer.nmr.mgh.
harvard.edu) was used for this project.
Limitations: Only global hippocampal labeling, no subﬁelds.
3. Statistics
All volumes were corrected for intracranial volume (ICV calculated
by FreeSurfer) using the following formula: corrected volume = vo-
lume × 1000/ICV. Multiple linear regression analyses with subﬁeld
volume as dependent and diagnostic Group, MCI status, SUVR (Abeta)
or cognitive measures (ADAScog, RVLT immediate recall) as in-
dependent variables of interest and age (all comparisons) and education
(cognitive associations only) as independent nuisance variables were
performed. The impact of the nuisance variable gender was investigated
but found to be non-signiﬁcant after correcting for ICV and hence not
included in the ﬁnal statistical model. The R2 from these regression
analyses were used to calculate standardized eﬀect size and power
(signiﬁcance level alpha = 0.05) for the number of the subjects in the
actual analysis and not for a ﬁxed number of subjects. Eﬀect sizes are
reported rather than the more common p-values because the purpose of
this paper was not to report that these subﬁeld approaches are able ﬁnd
signiﬁcant diﬀerences between groups etc. but rather to provide in-
formation about how large these diﬀerences are (Sullivan and Feinn,
2012). Statistical analyses were done in JMP12 (SAS Institute Inc.) and
GPower 3.1 (http://www.gpower.hhu.de). SINGLEBAYES.EXE
(Crawford and Garthwaite, 2007) was used to identify eﬀect sizes that
were signiﬁcantly higher (p < 0.05, one tailed) than others in each
comparison.
Considering that all three diagnostic comparisons, i.e., comparisons
1–3, were designed to detect hippocampal atrophy caused by AD, it was
expected that the order of the subﬁelds when ranked from largest to
smallest eﬀect would be similar for each of these comparisons, e.g., if
CA1 had the largest eﬀect size for MCI, it was expected that it would
also be the case for Abeta. The consistency of the eﬀect size ranking for
the diﬀerent subﬁelds was investigated using Pearson's correlation
coeﬃcients for each side separately, i.e., the eﬀect sizes for comparison
1 were correlated with those from 2 and 3 and those from comparison 2
were correlated with comparison 3 and the mean of the resulting cor-
relation coeﬃcients calculated.
4. Results
4.1. Group comparisons and amyloid eﬀects
Please see Table 2a–2c for detailed eﬀect sizes and power estimates
of every subﬁeld. With one exception, the manual labeling approach
identiﬁed CA1 or CA1-CA2 transition volumes as the subﬁelds with the
largest eﬀect sizes for diagnostic and neuropsychological variables of
interest. This consistency was also reﬂected in the high correlation
coeﬃcients (mean r left = 0.61, mean r right = 0.61). The FS 6.0 ap-
proach identiﬁed CA4 and CA1 as having the largest eﬀect sizes for the
overall group comparison, ﬁmbria and CA4 as having the largest eﬀect
size for the comparison between MCI and cognitively normal and
subiculum and molecular layer as having the largest eﬀect size for the
Table 2a
Eﬀect sizes to detect “Group” eﬀects.
Red, subﬁelds with the highest power for alpha = 0.05 and eﬀect size for each method; bold, method with best performance; *, subﬁeld with signiﬁcantly higher eﬀect size than other
subﬁelds within this comparison. PHIPPO, parahippocampus, ERC entorhinal cortex; BA, Brodmann Area; PreSub, presubiculum, ParaSub, parasubiculum, SUB, subiculum, CA, cornu
ammonis sector, Mol Lay, molecular layer, GC-ML-DG, granule cell layer of dentate gyrus, DG, dentate gyrus, HIPPO tail, posterior section of hippocampus, Total Hippo, total hippo-
campal volume from FreeSurfer.
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comparison between amyloid positive and negative cognitively intact
subjects. The inconsistency of the subﬁelds identiﬁed as having the
largest eﬀect size in these tests was reﬂected in low correlation coeﬃ-
cients (mean r left =−0.16, mean r right =−0.16). ASHS identiﬁed
the CA sector as having the largest eﬀect sizes to detect group eﬀects,
BA36 and DG has having the largest eﬀect sizes to detect diﬀerences
between cognitively intact subjects and subjects diagnosed with MCI
and parahippocampal gyrus and entorhinal cortex as having the largest
eﬀect size to detect amyloid associated subﬁeld atrophy. The ranking of
the eﬀect sizes and thus consistency of the detected eﬀects was low with
r=−0.27 on the left side but higher on the right side r= 0.3.
T1 based shape analysis identiﬁed CA1 and dentate as the subﬁelds
with the largest eﬀect sizes for eﬀect of group, and subiculum and CA1
as the subﬁelds with the largest eﬀects sizes to detect diﬀerences be-
tween cognitively intact and impaired subjects and amyloid positivity.
Since the shape analysis only identiﬁes 3 subﬁelds, a formal consistency
Table 2b
Eﬀect sizes distinction MCI vs. cognitively intact elderlies.
Red, subﬁelds with the highest power for alpha = 0.05 and eﬀect size for each method; bold, method with best performance. *, subﬁeld with signiﬁcantly higher eﬀect size (p < 0.05)
than other subﬁelds within this comparison. PHIPPO, parahippocampus, ERC entorhinal cortex; BA, Brodmann Area; PreSub, presubiculum, ParaSub, parasubiculum, SUB, subiculum,
CA, cornu ammonis sector, Mol Lay, molecular layer, GC-ML-DG, granule cell layer of dentate gyrus, DG, dentate gyrus, HIPPO tail, posterior section of hippocampus, Total Hippo, total
hippocampal volume from FreeSurfer.
Table 2c
Eﬀect sizes for the amyloid eﬀects on hippocampal subﬁelds in cognitively intact amyloid positive and negative controls.
Red, subﬁelds with the highest power for alpha = 0.05 and eﬀect size for each method; bold, method with best performance. *, subﬁeld with signiﬁcantly higher eﬀect size (p < 0.05)
than other subﬁelds within this comparison. PHIPPO, parahippocampus, ERC entorhinal cortex; BA, Brodmann Area; PreSub, presubiculum, ParaSub, parasubiculum, SUB, subiculum,
CA, cornu ammonis sector, Mol Lay, molecular layer, GC-ML-DG, granule cell layer of dentate gyrus, DG, dentate gyrus, HIPPO tail, posterior section of hippocampus, Total Hippo, total
hippocampal volume from FreeSurfer.
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assessment with Pearson correlation coeﬃcients was not possible. FS
Sub identiﬁed the ﬁmbria as having the largest eﬀect sizes for the dif-
ferentiation between cognitively intact and impaired subjects, sub-
iculum and hippocampal tail as having the largest eﬀect sizes to detect
a group eﬀect and hippocampal tail and CA2/CA3 as having the largest
eﬀect size to detect amyloid eﬀects in cognitively intact controls. The
ranking of the eﬀect sizes was low on the left side with r=−0.003 and
moderate on the right side with r= 0.26. With exception of the eﬀect
size for group eﬀect, the eﬀect sizes of total hippocampal volume de-
rived from FS Hippo was lower than those seen by the T2 high re-
solution image based approaches. The means of the subﬁelds with the
highest power and eﬀect sizes for each T2 method (values in red in
Table 2a–2c, Table 3) were generally higher than those of the T1 based
methods for all three comparisons (cf. Table 4).
A well acknowledged problem of all subﬁeld labeling approaches in-
cluding those chosen for this project is the lack of a common set of rules to
identify their boundaries which makes a direct comparison of the ﬁndings
across diﬀerent labs diﬃcult (Yushkevich et al. 2015). Although the
identiﬁcation of a common set of rules for subﬁeld labeling was beyond
the scope of this project, it is possible to combine labels from more de-
tailed protocols to mimic the parcellations of less detailed protocols. The
less detailed protocol used by ASHS and shape analysis consisted of a CA
label, a DG label and a subiculum label. The CA label was mimicked for
the manual approach by combining the CA1 and CA1–2 transition zone
volumes, for FS 6 by combining the volumes for subiculum, CA1, CA2/3
and molecular layer and for FS Sub by combining the volumes for sub-
iculum, CA1, CA2/3. The presubiculum label of FS 6.0 and FS Sub cor-
responds to the subiculum label of ASHS, shape analysis and the manual
approach. The DG label for FS 6.0 was mimicked by combining the labels
of CA4 and granular cell layer dentate. The DG estimates for the manual
labeling was based on its CA3&DG volume and those for FS sub on its
CA4-DG label. Fig. 2 shows the eﬀect sizes for these compounded labels.
Using the compounded labels, all three high resolution T2 based ap-
proaches identiﬁed left and right CAc as the subﬁeld with the highest
eﬀect size for group. Manual labeling and FS 6.0 identiﬁed left and right
CAc and ASHS right CAc but left subiculum with left CAc as a close
second as the most aﬀected combined label for Abeta eﬀects. All three
identiﬁed either CAc or DG as the most aﬀected subﬁeld for the MCI
eﬀects. Taken together, simplifying parcellation schemes by com-
pounding labels increased the consistency within each approach and
across the three approaches. FS SUB identiﬁed left and right subiculum as
the region with the largest group eﬀect and left and right DG as the region
with the largest MCI eﬀect. Right CAc and left subiculum with left CAc as
a close second showed the largest eﬀect sizes for Abeta with the FS SUB
approach. The use of the compounded labels also increased the con-
sistency of the ﬁndings within FS SUB but not of those of high resolution
T2 based approaches.
4.2. Subﬁeld volumes as predictor of cognitive function in cognitively intact
subjects
Left and right volumes were averaged for this assessment. Please see
Table 3 for the detailed results. The manual approach identiﬁed CA1
and CA1–2 transition as having the largest eﬀect sizes for ADAScog and
RVLT immediate recall. FS 6.0 identiﬁed the presubiculum as the sub-
ﬁeld with the largest eﬀect for ADASCog and the dentate granular cell
layer volume as the subﬁeld with the largest eﬀect size for immediate
RVLT recall. ASHS found that ERC had the largest eﬀect size for
Table 3
Eﬀect sizes for the association subﬁeld volumes with cognition in healthy controls: ADAScog and RAVLT immediate.
Red, subﬁelds with the highest power for alpha = 0.05 and eﬀect sizes for each method; bold, method with best performance. *, subﬁeld with signiﬁcantly higher eﬀect size (p < 0.05)
than other subﬁelds within this comparison. PHIPPO, parahippocampus, ERC entorhinal cortex; BA, Brodmann Area; PreSub, presubiculum, ParaSub, parasubiculum, SUB, subiculum,
CA, cornu ammonis sector, Mol Lay, molecular layer, GC-ML-DG, granule cell layer of dentate gyrus, DG, dentate gyrus, HIPPO tail, posterior section of hippocampus, Total Hippo, total
hippocampal volume from FreeSurfer. ADAScog, Alzheimer's Disease Assessment Scale – cognition; RAVLT, immediate recall of the Rey Auditory verbal learning test.
Table 4
Comparison of power and eﬀect sizes of T2 and T1 based subﬁeld approaches.



















Group 1.0000 0.9900 0.24 0.5584 0.4419 0.33 1.0000 0.5042
MCI 0.9438 0.6241 0.02 0.1771 0.0768 0.01 0.8359 0.1122
Abeta 0.3051 0.1643 0.06 0.0749 0.0467 0.18 0.0742 0.0081
Cog 0.6659 0.5146 0.26 0.1850 0.1369 0.37 0.5102 0.1248
High Res T2 includes manual labeling, ASHS and Freesurfer 6.0 subﬁelds.
Whole Brain T1 includes shape analysis and Freesurfer 5.1 subﬁelds.
P-value, p for comparion T2 vs T1 subﬁeld approach.
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ADAScog and that CA had the largest eﬀect size for immediate RVLT.
Shape analysis identiﬁed the dentate gyrus as having the largest eﬀect
size for ADAScog and CA1 as the subﬁeld with the largest eﬀect size for
RVLT immediate recall. Finally, FS Sub subﬁelds showed the same
pattern as FS 6.0, i.e., presubiculum had the highest eﬀect size for
ADAScog and CA4&dentate had the highest eﬀect size for RVLT im-
mediate recall. The means of the subﬁelds with the highest power and
eﬀect sizes for each T2 method (values in red in Table 2a–2c, Table 3)
were generally higher than those of the T1 based methods for all both
comparisons (cf. Table 4).
5. Discussion
The comparison revealed two major ﬁndings. 1. It was possible to
acquire T2 high resolution hippocampal images in a large multi-site
project that were comparable regarding image quality and accurate and
consistent positioning to images acquired for dedicated small research
projects where a one-to-one training and immediate feedback regarding
quality are possible. This is an important step for this technique's suc-
cessful transition from a research tool to a clinical routine procedure. 2.
Using eﬀect size as criterion subﬁeld volumetry but especially ap-
proaches using a T2 high resolution image outperformed traditional
hippocampal volumetry regarding their ability to detect conditions
characterized by subtle hippocampal atrophy, i.e., comparisons be-
tween MCI vs CN, amyloid neg vs pos, and associations subﬁeld cog-
nition/memory in cognitively intact subjects. T2 high resolution ap-
proaches also outperformed subﬁeld approaches using the whole brain
T1 image for the comparisons between MCI vs CN and amyloid neg vs
pos. However, the T2 high-resolution approaches identiﬁed diﬀerent
subﬁelds as having the highest eﬀect sizes for these comparisons. This
was not unexpected given the diﬀerences of the labeling scheme.
Reducing the diﬀerences of parcellation schemes between the three T2
Fig. 2. Bar plots of eﬀect sizes for combined labels. CA
corresponds to all cornu ammonis labels, DG corresponds to
the dentate gyrus and Sub to the subiculum. Please see text
for a description how these labels were generated for each of
the approaches. “Group” refers to the ability to detect a
group eﬀect in a population consisting of cognitively normal
elderly controls, non-demented subjects with diﬀerent de-
grees of mild cognitive impairment and subjects diagnosed
with Alzheimer's Disease. ‘MCI’ refers to the ability to detect
a group eﬀect on subﬁeld and mesio-temporal volumes in a
population consisting of cognitively normal elderly controls,
and non-demented subjects with diﬀerent degrees of mild
cognitive impairment. ‘Abeta’ is the ability to detect an ef-
fect of amyloid positivity on subﬁeld and mesio-temporal
volumes in cognitively normal subjects.
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high resolution approaches by combining labels and generating com-
pounded labels eliminated left/right diﬀerences within each method
and increased the consistency for the identiﬁcation of the most aﬀected
region across methods. None of the diﬀerent T2 high resolution
methods tested had a clear advantage over the other methods. Each has
strengths and weaknesses that need to be considered when deciding
which one to use to get the best results from subﬁeld volumetry in AD.
Attempts to use high resolution T2 images to measure subﬁeld vo-
lumes have been made since the introduction of the hippocampal un-
folding technique by Zeineh et al. (2001) and have been intensiﬁed
after 3 T magnets became widely available in academic hospitals and
research institutions in the last decade. Despite its popularity for re-
search and the development of reliable, fast and computationally eﬃ-
cient automated subﬁeld volumetry approaches quantitative hippo-
campal subﬁeld volumetry has yet to make the transition from research
to clinical application. One of the reasons for the delay is the relatively
lengthy acquisition time of about 9–13 min which is rather long for a
busy clinical setting. For this project, this issue was addressed by
shortening the acquisition time to about 8 min. Another reason is the
need for careful positioning that requires some knowledge of hippo-
campal anatomy. Despite detailed instructions incorrect positioning
with insuﬃcient coverage of the hippocampus was a problem in the
early phase of this project and resulted in the exclusion of about 8% of
all acquired images. The problem was eliminated after adding the po-
sitioning information as a tab to the information displayed at the MR
console. The images acquired for ADNI2 were of similar quality as those
acquired in research settings. 12% were rated as not suitable for pro-
cessing mostly due to motion artifacts or poor contrast in the hippo-
campal formation which compares well with the percentage of images
excluded from processing in this population in research settings. Taken
together, it can be concluded that it is possible to obtain high resolution
T2 hippocampal images of suitable quality for manual and automated
subﬁeld labeling within a reasonable acquisition time in a multi-site
project which makes it possible to use this sequence in imaging pro-
tocols for drug trials or for clinical purposes.
There are two ways to assess the performance of diﬀerent subﬁeld
volumetry approaches. The ﬁrst is statistical eﬃciency which compares
approaches based on eﬀect size or minimal number of subjects needed
to ﬁnd any statistical diﬀerence. The second is biological plausibility
which addresses the question to what degree the measurement with the
highest eﬀect size corresponds to the known histopathological features
of the disease process. AD is characterized by a well-deﬁned progres-
sion of its histopathological hallmarks amyloid plaques and neuroﬁ-
brillary tangles. Particularly the latter has been shown to be closely
associated with cognitive performance and neuron loss within the
hippocampus and mesio-temporal lobe (Giannakopoulos et al., 1996;
Giannakopoulos et al., 2007; Fukutani et al., 2000). The earliest site of
neuroﬁbrillary tangle accumulation in the preclinical state of AD is the
trans-entorhinal cortex (BA 35) followed by the entorhinal cortex. The
tangles then progress to the hippocampus where they cause the most
prominent neuron loss in CA1 followed by that in the subiculum while
the dentate gyrus is relatively spared in the early clinical stages (West
et al., 1994). Subﬁeld volumetry should ideally show the same kind of
progression, i.e., the most prominent volume loss in the trans-en-
torhinal cortex/entorhinal cortex in the early preclinical phase followed
by volume loss in CA1 (MCI and early AD) and subiculum (early AD)
and aﬀect the dentate/hilus region in the more advanced stages. Based
on these considerations, CA1 and entorhinal cortex would be expected
to show the highest eﬀect sizes in all comparisons except for “group”
where subiculum and eventually dentate gyrus are also aﬀected.
Regarding statistical eﬃciency the ﬁndings of this project replicated
those of previous studies (e.g., De Flores et al., 2015; Mueller et al.,
2010) that showed that subﬁeld volumetry based on a T2 high
resolution image outperforms hippocampus volumetry for the detection
of subtle and more localized atrophy characterizing the early stages of
AD as evidenced by the power and eﬀect size calculations for “MCI” and
“Abeta”. This was expected given that the increased accuracy for the
detection of subtle atrophy was one of the major reasons for the de-
velopment of subﬁeld volumetry. Nonetheless, it is satisfying that this
assumption was conﬁrmed for all T2 high resolution approaches in-
vestigated here.
Approaches based on a high resolution T2 hippocampal image had
typically higher eﬀect sizes than subﬁeld approaches using the lower
resolution whole brain T1. This ﬁnding was also not unexpected. The
myelinated tissue of the stratum moleculare and lacunosum appears as
a very characteristic hypointense line in this image and its acquisition
parameters are usually set to maximize this contrast in the population
of interest. In contrast, T1 based subﬁeld approaches use standard
whole brain T1 weighted images with a lower resolution whose contrast
has not been optimized for the hippocampus. On such images the
stratum moleculare and lacunare is slightly hyperintense compared to
the surrounding tissue and far less prominent although it is possible to
enhance it by acquiring and averaging multiple T1 images. Without any
strong information from the internal structure though, subﬁeld par-
cellation by FS SUB is mostly guided by the outer hippocampal
boundaries and by the information from the probabilistic prior. This
limitation and the simpliﬁed non-anatomical parcellation scheme re-
duce the ability of FS SUB to detect subtle disease related atrophy and
explain why the subﬁelds with highest eﬀect sizes for the diﬀerent
comparisons, do not reﬂect the known atrophy pattern very well despite
large eﬀect sizes. The rationale behind subﬁeld volumetry based on
hippocampal shape analysis inherently acknowledges the limited in-
formation about the internal structure in the T1 image and tries instead
to optimize the information provided by the outer boundaries.
However, the ability of surface-based approaches to detect subtle dis-
ease related eﬀects is on the one hand limited by the existence of
physiological shape variants, e.g., the varying number of digitations in
the hippocampal head or rotational variants of the body, and on the
other hand by the fact that abnormalities restricted to a speciﬁc subﬁeld
are often not well reﬂected on the surface. In addition, the shape
measure used in this analysis was the univariate summary index, se-
lected to be comparable to other methods. Multivariate approaches are
better suited to capture shape diﬀerences due to group diﬀerences.
These limitations explain why shape analysis had the lowest eﬀect sizes
of the subﬁeld speciﬁc approaches for comparisons assessing subtle
atrophy. It is important to emphasize in this context that the area where
shape analysis is likely to outperform the other approaches, i.e. its
ability to identify the region of maximal atrophy along the anterior-
posterior axis, was not tested in this project.
If eﬀect size is used as the sole criterion, none of the diﬀerent high
resolution hippocampal T2 based approaches consistently out-
performed the other approaches, i.e., the eﬀect size diﬀerences between
the best performing labels of the three T2 based approaches were small
and mostly not signiﬁcant. This leaves the question how well they were
able to detect the atrophy pattern associated with the disease process.
One of the major criticisms of the manual labeling approach used for
this project is that the labeling is restricted to the anterior third of the
hippocampal body. While there is no doubt that this approach would
miss localized atrophy in the posterior body, its eﬀect sizes for the
detection of a less focal atrophy pattern compared well with the auto-
mated whole hippocampus labeling approaches. The manual labeling
identiﬁed CA1 or the neighboring CA1–2 transition area as the most
prominently aﬀected subﬁelds except for the “MCI” comparison in the
right hippocampus where the largest eﬀect size was found in the den-
tate gyrus and CA3 area. The ranking of the eﬀect sizes for the manual
labeling was also quite consistent across the comparisons. It is possible
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that the limited labeling approach that excluded diﬃcult to trace re-
gions such as the hippocampal head and tail contributed to the con-
sistency of the ﬁndings. ERC however had often the smallest eﬀect sizes
in these comparisons. The poor performance of ERC for the manual
labeling was not unexpected. The re-slicing of the image that is ne-
cessary to optimize the cross-section for hippocampal labeling and the
limited coverage of the ERC often aggravate partial volume artifacts in
the ERC region and thus the non-disease related variability. This was
diﬀerent for ASHS. Except for the “group” comparison that identiﬁed
CA as the most aﬀected subﬁeld and the “cognitively normal vs MCI”
comparison that identiﬁed the right dentate gyrus as having the largest
eﬀect size, ASHS identiﬁed ERC, neighboring Brodmann Area (BA) 36
or the parahippocampus as the regions with the highest eﬀect size with
CA usually a close second. This is not surprising since ASHS is the only
labeling approach evaluated here that has been optimized for en-
torhinal/perirhinal volumetry. It is the only approach that has a sepa-
rate label for the transentorhinal cortex or BA 35 (Taylor and Probst,
2008) although the other, larger entorhinal/perirhinal labels out-
performed the BA 35 volume in all comparisons. A downside of the
detailed entorhinal/perirhinal labels was that it aﬀected the con-
sistency of the ranking order of the eﬀect sizes. FS 6.0 uses the most
detailed parcellation for hippocampal subﬁeld labeling of all ap-
proaches investigated here. The detailed labeling makes the assessment
of this approach somewhat challenging because there exist no histo-
pathological studies that systematically investigated the distribution of
AD related abnormalities across layers of diﬀerent subﬁelds. As seen in
the assessment of the other high resolution T2 based methods, the
subﬁelds showing the largest eﬀect sizes varied between comparisons
and the consistency of the eﬀect size order across comparisons was low.
The higher number of labels in FS 6.0 likely contributed to the low
consistency. Reducing the complexity of the labeling scheme by com-
bining labels increased the consistency of the ﬁndings between left and
right hippocampal volumes for each T2 approach and also across T2
approaches but reduced the eﬀect sizes.
The observations regarding detailed labeling schemes in the pre-
vious paragraph point to another important requirement for biologi-
cally meaningful subﬁeld labeling. The input images need to con-
sistently depict a minimal set of landmarks for these parcellation
schemes to work well. This minimal number is higher for more detailed
parcellations than for less sophisticated schemes. Furthermore, outputs
from automated subﬁeld labeling routines should undergo a rigorous
visual quality control by raters who know the hippocampal anatomy
well enough to spot labeling inaccuracies. Such a quality control step
becomes more complicated with elaborate parcellation schemes that
require expert knowledge. These concerns raise the question if these
detailed rhinal and hippocampal parcellations of ASHS and FS 6.0
should not be reserved for high quality 3 T images with motion cor-
rection or even 7 T images that depict the landmarks reliably and are
addressing hypotheses that require such a detailed parcellation while
projects that do not acquire this kind of high quality image and do not
have layer speciﬁc hypotheses should consider reducing the complexity
of the labeling by combining to enhance reliability and reproducibility
across projects.
As mentioned before, each of T2 high resolution methods has its set
of strengths and weaknesses. Manual segmentation is time consuming
and therefore not an option for the processing of large datasets en-
compassing hundreds of images. It also requires experienced, specially
trained rater(s) who are not available everywhere. However, this
weakness can also turn into a strength because experienced raters can
adapt more easily to physiological and pathological shape and contrast
variants of the hippocampus than atlas-based automated subﬁeld la-
beling approaches. ASHS, on the other hand, is based on multi-atlas
segmentation, which has become a very popular segmentation
approach in recent years, and produces state-of-the-art results in many
medical image segmentation tasks. However, ASHS relies on the accu-
racy of an intensity-matched registration of the images to be segmented
to a library of labeled images which is likely to suﬀer if the former has
been acquired with a diﬀerent sequence or platform than the atlas
images. In the case of ASHS, this can be overcome by generating po-
pulation and magnet speciﬁc libraries, but this usually requires again
the input of expert raters who select the appropriate images and edit the
library labels. FS 6.0's main advantage is that its intensity models are
learned directly from the individual scan to be segmented, which makes
it less dependent on magnet type and sequence. However, FS 6.0 uses
the probabilistic information from an ex vivo atlas for this process and
thus its performance will be impaired in cases where the intensity
distribution deviates too much from the atlas due to shape variants or
due to the disease processes.
In conclusion, subﬁeld volumetry outperformed hippocampal vo-
lumetry in their ability to detect subtle atrophy that characterizes the
early stages or preclinical stages of AD: T2 high resolution based ap-
proaches performed better than T1 based approaches but the latter have
the advantage that they do not require the acquisition of a dedicated
image. The automated T2 based subﬁeld labeling approaches tested in
this project compared well with the manual approach and their accu-
racy is likely to further improve in the future. However, just as for
manual labeling approaches, the accuracy of the automated algorithms
depends on the quality of the image that is being labeled and on how
well the atlas or a priori information used by the algorithm reﬂects the
process of interest.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nicl.2017.12.036.
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